Estimation of Fibrinogen level among Sudanese women with recurrent miscarriage
Abstract
Background: Recurrent Spontaneous abortion (RSA) is defined as consecutive pregnancy loss before 20 weeks gestation and it has been attributed to either genetic, structural infective, endocrine, immune, or unexplained causes
Material and methods: This study was case – control study conducted at the Algophran medical laboratory, Khartoum, Sudan during the period July to November, 2021 and aimed to estimate the fibrinogen level among Sudanese women with recurrent miscarriage. 50 patients attending obstetrics and gynecology unit at Ibrahem Malik teaching hospital and diagnosed with recurrent spontaneous abortion during the aforementioned period were selected as cases group. In addition to that, 50 apparently healthy women with no history of abortion and without any other risk factor related to abortion were selected as control group. From each participant 5ml of venous blood samples were dispensed into sterile containers with tri-sodium citrate anticoagulant container. Fibrinogen level was estimated by using the coagulometer (Automated Bio Bas) by BioMed-Fibrinogen kite
Result: The results showed; when compared the fibrinogen level between cases and control group there was significant decreased of fibrinogen level with (P = 0.000). Also in the case group there was insignificant differences between fibrinogen level and age , number of miscarriages and the gestational age (P >0.05)
Conclusion: In the conclusion the result showed significant decreased of the fibrinogen level and insignificant differences between fibrinogen level and age, number of miscarriages and the gestational age among Sudanese women with recurrent miscarriage.
Keywords: Recurrent Miscarriage, Pregnancy, Fibrinogen, Genetic, Abortion And Endocrine
Keywords:
Recurrent Miscarriage, Pregnancy, Fibrinogen, Genetic, Abortion, EndocrineDOI
https://doi.org/10.22270/jddt.v11i6-S.5149References
Asaad Mohammed Ahmed Abd Allah Babker1, SalaheldeinGumaa Elzaki2, Sarah ElsiddigDafallah. 2015. An Observational Study of Causes of Recurrent Spontaneous Abortion among Sudanese Women. IJSR; 4(9):1435-1438.
Athira Sasidharan, Aboobacker Mohamed Rafi, Ramesh Bhaskaran, Nithya M Baiju, Susheela Jacob Innah. 2021. Successful Pregnancy in a Patient With Recurrent Pregnancy Loss Due to Afibrinogenemia Managed With Cryoprecipitate Prophylaxis in a Resource-limited Setting. Mal J Med Health Sci 17(2): 308-310
Bolton-Maggs PH. 2006. The rare coagulation disorders. Treatment of hemophilia.; 39: 1-11
Casini A, de Moerloose P.2016. Management of congenital quantitative fibrinogen disorders: a Delphi consensus. Haemophilia ; 22: 898-905. https://doi.org/10.1111/hae.13061
Evans M: Recurrent pregnancy loss. available from Huntington reproductive in California: URL: http://www.infertilityspecialist.com/recurrent_pregnancy_loss.htm (Accessed on December, 2011).
Evron, S., Anteby, S.O., Brzezinsky, A., Samueloff, A., and Eldor, A. 1985. Congenital afibrinogenemia and Recurrent early abortion: a case report. Eur. J. Obstet. Gynaecol. Reprod. Biol ;19(5), 307-311. https://doi.org/10.1016/0028-2243(85)90046-2
Ford H B, Schust D J. 2009. Recurrent Pregnancy Loss: Etiology, Diagnosis, and Therapy. Rev Obstet Gynecol; 2: 76-83
Iwaki T, Mayra J, Cooper S.2002. Fibrinogen stabilizes placental- maternal attachment during embryonic development in the mouse. Am J Path; 160: 1021-34 https://doi.org/10.1016/S0002-9440(10)64923-1
Jaslow CR, Carney JL, Kutteh WH. 2010. Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses. FertilSteril ;93(4):1234-1243. https://doi.org/10.1016/j.fertnstert.2009.01.166
Lang, T., Johanning, K., Metzler, H., Piepenbrock, S., Solomon, C., Rahe-Meyer, N., Tanaka, K.A. 2009. "The effects of fibrinogen levels on thromboelastometric variables in the presence of thrombocytopenia". Anesth Analg 108 (3), 751-8.5. https://doi.org/10.1213/ane.0b013e3181966675
Miesbach W, Galankis D, Scharrer I. 2009. Treatment of patients with dysfibrinogenemia and history of abortions during pregnancy. Blood Coagul Fibrinolysis ; 5: 366-70 https://doi.org/10.1097/MBC.0b013e32832aec2b
Naz A, Biswas A, Khan TN, Goodeve A, Ahmed N, et al. 2017 Identification of novel mutations in congenital afibrinogenemia patients and molecular modelling of missense mutations in Pakistani population. Thromb J ; 15: 24 https://doi.org/10.1186/s12959-017-0143-3
Pavord S, Rayment R, Madan B, et al. Management of Inherited Bleeding Disorders in Pregnancy. Green-top Guideline No. 71. BJOG 2017; 124:e193-e263. https://doi.org/10.1111/1471-0528.14592
Robbi A. Wicaksono, Jusuf S. Effendi, Budi Handono . 2011. Comparison of Fibrinogen Level Changes between Pregnancy with History of Abortion and Normal Pregnancy. Indones J Obstet Gynecol; 35( 2):53-56
Thornton P, Douglas J. 2010. Coagulation in Pregnancy. Best Practice and Research Clinical Obstetrics and Gynaecology; 24: 340 https://doi.org/10.1016/j.bpobgyn.2009.11.010
Wang, S., Retzinger, G.S.2002. Hypercoagulability during pregnancy. Lab Lines ; 8(5), 1-4.
World Health Organization (WHO). Unsafe abortion: global and regional estimates of the incidence of unsafe abortion and associated mortality in 2000, 4th edn. Geneva: WHO, 2004
Published
Abstract Display: 622 
PDF Downloads: 503 PDF Downloads: 42 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.